muscular dystrophies

25 projects

HEIndividual fellowship2026–2028France

SKM-REFORMAT · SKeletal Muscle - REgulation of FORce and Maturation through Tubulin isotypes

HEDoctoral network2025–2029France

ENTRY-DM · Interdisciplinary doctoral training on oligonucleotide-based therapies for myotonic dystrophy

29 partners · 9 countries

HEIndividual fellowship2024–2027Italy

MyoPALM · Deciphering the role of protein S-palmitoylation in skeletal muscle physiopathology

2 partners · 2 countries

H2020Individual fellowship2021–2024Italy

Myo_LysoZOOM · An insight into lysosomal signature in muscle wasting

2 partners · 2 countries

H2020Individual fellowship2021–2023France

MUMDUPSC · Modelling undiagnosed muscular dystrophies using patients's stem cells

H2020Individual fellowship2021–2025France

DYSTROPHIC-ECM · Active role of skeletal muscle extracellular matrix in muscular dystrophies

H2020Individual fellowship2021–2023Italy

DREAM · Dux4-Regulated Expression and Activity by an inhibitor Molecule

H2020Individual fellowship2020–2022United Kingdom

RE-GENESis · GENome Editing and delivery Strategies for REcoding the mammalian genome

H2020Individual fellowship2019–2022Greece

MechanoGenetic · Role of mechanical forces in cell-matrix adhesion sites

H2020Individual fellowship2018–2020Netherlands

DUX4 · Function of DUX4 in skeletal muscle and non-muscle tissues

H2020Individual fellowship2017–2019Switzerland

MuSCel Genome · Muscle Specific C. elegans Genome in health and disease: finding novel factors in 3D organization

H2020Individual fellowship2017–2019Germany

VGAP · The Viral Genome Associated Proteome

H2020Individual fellowship2017–2019France

DMD2CURE · Correction of duplications in the DMD gene by a CRISPR/Cas9 approach

H2020Individual fellowship2016–2018Israel

channelopathies · Type 1 reyanodine receptor Structure and regulation by post-translational modifications and small molecules.

H2020Individual fellowship2016–2017United Kingdom

Subpopulations · Investigating Fibrotic and Regenerative Fibroblast Populations in Muscular Dystrophy

H2020Individual fellowship2016–2017United Kingdom

DYS_FUNCTION · Novel use of exon skipping technology to study structure-function relationship of dystrophin

H2020Individual fellowship2016–2018United Kingdom

INAME · Imaging nucleic acid metabolism in cells

H2020Individual fellowship2015–2017Denmark

PIOMES · Pbx proteins as pioneer factors promoting signal specificity in mesodermal differentiation

FP7Reintegration grant2013–2017Spain

ANTES · Accelerating Neuromuscular Treatment Selection

FP7Reintegration grant2010–2014Spain

LGMD2A · Development of a strategy to treat limb-girdle muscular dystrophy (LGMD2A) using combined cell and gene therapy strategies

2 partners

FP7Individual fellowship2010–2012Spain

STROKECELLFUSION · Cell fusion as regenerative tool for stroke treatment

FP6Reintegration grant2006–2008Italy

FSHD ANIMAL MODEL. · An animal model to develop therapeutic strategies for facioscapulohumeral muscular dystrophy, FSHD

FP6Individual fellowship2005–2007France

DM BRAIN · Dissecting the molecular pathways of brain dysfunction in myotonic dystrophy

FP5Individual fellowship2002–2003Italy

Real-time analysis of the induction of apoptosis in duchene muscular dystrophy